Clinical Trial

Intrathecal Morphine Versus Intravenous Methadone for Postoperative Analgesia Following Retroperitoneal Lymph Node Dissection.

Study acronym: RPLND
Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
This randomization study is to compare both intrathecal morphine and intravenous methadone, which are both standard of care, for pain management in patients undergoing retroperitoneal lymph node dissections for primary testicular cancer. Investigators plan to compare their analgesic effectiveness at different postoperative time intervals.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2024-09-09; most recent amendment 2026-02-11.
Status change: Not Yet Recruiting → Recruiting 2024-11-11
Trial Details
NCT Number NCT06593665
Lead Sponsor Indiana University
Conditions Testicular Cancer
Enrollment 142 participants
Start Date 2024-09-10
Primary Completion 2026-12-31 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-02-13